Logo image of ARQ

ARQ INC (ARQ) Stock Fundamental Analysis

NASDAQ:ARQ - Nasdaq - US00770C1018 - Common Stock - Currency: USD

3.52  -0.22 (-5.88%)

Fundamental Rating

3

Taking everything into account, ARQ scores 3 out of 10 in our fundamental rating. ARQ was compared to 85 industry peers in the Chemicals industry. ARQ has a bad profitability rating. Also its financial health evaluation is rather negative. ARQ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ARQ had negative earnings in the past year.
In the past year ARQ had a positive cash flow from operations.
ARQ had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARQ reported negative operating cash flow in multiple years.
ARQ Yearly Net Income VS EBIT VS OCF VS FCFARQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

ARQ has a Return On Assets of -1.80%. This is in the lower half of the industry: ARQ underperforms 69.41% of its industry peers.
ARQ has a Return On Equity of -2.35%. This is in the lower half of the industry: ARQ underperforms 62.35% of its industry peers.
Industry RankSector Rank
ROA -1.8%
ROE -2.35%
ROIC N/A
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ARQ Yearly ROA, ROE, ROICARQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

ARQ's Gross Margin of 36.20% is fine compared to the rest of the industry. ARQ outperforms 74.12% of its industry peers.
ARQ's Gross Margin has improved in the last couple of years.
ARQ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
ARQ Yearly Profit, Operating, Gross MarginsARQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

3

2. Health

2.1 Basic Checks

ARQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARQ has more shares outstanding
ARQ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARQ has been reduced compared to a year ago.
ARQ Yearly Shares OutstandingARQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ARQ Yearly Total Debt VS Total AssetsARQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

ARQ has an Altman-Z score of 2.13. This is not the best score and indicates that ARQ is in the grey zone with still only limited risk for bankruptcy at the moment.
ARQ has a Altman-Z score of 2.13. This is in the better half of the industry: ARQ outperforms 64.71% of its industry peers.
ARQ has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
ARQ has a better Debt to Equity ratio (0.11) than 84.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 2.13
ROIC/WACCN/A
WACC8.89%
ARQ Yearly LT Debt VS Equity VS FCFARQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

ARQ has a Current Ratio of 1.17. This is a normal value and indicates that ARQ is financially healthy and should not expect problems in meeting its short term obligations.
ARQ has a worse Current ratio (1.17) than 78.82% of its industry peers.
ARQ has a Quick Ratio of 1.17. This is a bad value and indicates that ARQ is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.74, ARQ is not doing good in the industry: 78.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.74
ARQ Yearly Current Assets VS Current LiabilitesARQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

ARQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.00%, which is quite impressive.
ARQ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.84%.
Measured over the past years, ARQ shows a quite strong growth in Revenue. The Revenue has been growing by 9.22% on average per year.
EPS 1Y (TTM)78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)9.84%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%-3.79%

3.2 Future

The Earnings Per Share is expected to grow by 65.14% on average over the next years. This is a very strong growth
Based on estimates for the next years, ARQ will show a quite strong growth in Revenue. The Revenue will grow by 18.96% on average per year.
EPS Next Y164.27%
EPS Next 2Y136.24%
EPS Next 3Y109.6%
EPS Next 5Y65.15%
Revenue Next Year17.1%
Revenue Next 2Y20.95%
Revenue Next 3Y21.37%
Revenue Next 5Y18.96%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ARQ Yearly Revenue VS EstimatesARQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
ARQ Yearly EPS VS EstimatesARQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ARQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 49.79, ARQ can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ARQ is valued a bit more expensive than 65.88% of the companies in the same industry.
ARQ is valuated expensively when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 49.79
ARQ Price Earnings VS Forward Price EarningsARQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

ARQ's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ARQ is more expensive than 75.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.08
ARQ Per share dataARQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

ARQ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ARQ's earnings are expected to grow with 109.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y136.24%
EPS Next 3Y109.6%

More info and screens

0

5. Dividend

5.1 Amount

ARQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARQ INC

NASDAQ:ARQ (4/21/2025, 2:30:18 PM)

3.52

-0.22 (-5.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-12 2025-05-12
Inst Owners33.13%
Inst Owner ChangeN/A
Ins Owners19.47%
Ins Owner Change9.4%
Market Cap147.88M
Analysts80
Price Target9.69 (175.28%)
Short Float %3.47%
Short Ratio3.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)56.58%
Min EPS beat(2)13.15%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)16.76%
Min EPS beat(4)-27.3%
Max EPS beat(4)100%
EPS beat(8)4
Avg EPS beat(8)10.13%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.07%
Min Revenue beat(2)-7.12%
Max Revenue beat(2)13.26%
Revenue beat(4)2
Avg Revenue beat(4)5.35%
Min Revenue beat(4)-7.12%
Max Revenue beat(4)22.1%
Revenue beat(8)5
Avg Revenue beat(8)5.76%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-300%
EPS NY rev (1m)-40%
EPS NY rev (3m)-48.78%
Revenue NQ rev (1m)-2.36%
Revenue NQ rev (3m)-16.22%
Revenue NY rev (1m)-9.25%
Revenue NY rev (3m)-10.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 49.79
P/S 1.36
P/FCF N/A
P/OCF 14.11
P/B 0.68
P/tB 0.71
EV/EBITDA 23.08
EPS(TTM)-0.11
EYN/A
EPS(NY)0.07
Fwd EY2.01%
FCF(TTM)-1.78
FCFYN/A
OCF(TTM)0.25
OCFY7.09%
SpS2.59
BVpS5.17
TBVpS4.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.8%
ROE -2.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.2%
FCFM N/A
ROA(3y)-3.97%
ROA(5y)1.37%
ROE(3y)-5.19%
ROE(5y)0.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.52%
GM growth 5Y4.26%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 3.46
Cap/Depr 993.15%
Cap/Sales 78.33%
Interest Coverage N/A
Cash Conversion 156.4%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 0.74
Altman-Z 2.13
F-Score5
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)475.88%
Cap/Depr(5y)322.19%
Cap/Sales(3y)39.34%
Cap/Sales(5y)27.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y164.27%
EPS Next 2Y136.24%
EPS Next 3Y109.6%
EPS Next 5Y65.15%
Revenue 1Y (TTM)9.84%
Revenue growth 3Y2.8%
Revenue growth 5Y9.22%
Sales Q2Q%-3.79%
Revenue Next Year17.1%
Revenue Next 2Y20.95%
Revenue Next 3Y21.37%
Revenue Next 5Y18.96%
EBIT growth 1Y88.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year764.57%
EBIT Next 3Y192.38%
EBIT Next 5Y110.35%
FCF growth 1Y-59.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y162.91%
OCF growth 3Y-26.14%
OCF growth 5Y-29.98%